INCR
InterCure Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$5.31
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.61x
- Price / sales
- 0.89x
- Price / cash flow
- 7.70x
Enterprise value
- Enterprise value
- $124.6M
- EV / sales
- 1.40x
- EV / EBITDA
- -6.82x
- EV / EBIT
- -13.86x
- Market cap
- $79.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025